AIBS 2016
Highlights of the 2016 edition include:
- Around 1,000 Australian businesses were surveyed, drawn from 19 industry sectors, 93 sub-sectors, and operating across more than 100 international
markets;
- China (17%), the United States (16%) and New Zealand (8%) were the most important markets for respondents, by international revenue;
- The biggest risks to respondent’s international operations were increased international competitor and the threat of economic or financial crisis in
key markets;
- Four in five respondents planned to do business in new markets over the next two years, led by China, the United States, India, the United Kingdom and Indonesia.
Country Reports
State Reports
Industry Reports
Join Us
Become A Member
Eric Meppem,
Co-Founder & Commercial Director,
Pharmako Biotechnologies Pty Ltd
Member of the ECA
"Pharmako Biotechnologies were already exporting when we joined the ECA. We joined to assist our export strategies, and unashamedly to promote ourselves
through the Australian Export Awards. As a small business, third party recognition and industry membership assist when dealing with large
multinational businesses."
Featured Member
.png?Action=thumbnail&algorithm=fill_proportional&width=262)
Established in 1970, Mavlab Animal Health Pty Ltd is a Queensland based, family-owned, GMP licenced manufacturer of veterinary pharmaceuticals and pet care products. Mavlab has an extensive range of prescription and over the counter
products sold in a growing number of global markets. Contract manufacturing opportunities are also available.